Company Filing History:
Years Active: 2025
Title: Adam Marc Levinson: Innovator in Pharmaceutical Research
Introduction
Adam Marc Levinson is a notable inventor based in Astoria, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for autoimmune diseases. His work has led to the creation of innovative compounds that target specific health conditions.
Latest Patents
Adam Marc Levinson holds 1 patent related to IL-17A inhibitors. This invention provides certain difluorocyclohexyl-imidazopyridazinyl-imidazolidinone compounds of formula II as IL-17A inhibitors. The patent outlines pharmaceutical compositions and methods for using these compounds to treat symptoms of psoriasis, rheumatoid arthritis, or multiple sclerosis.
Career Highlights
Levinson is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves extensive research and development, focusing on innovative solutions for complex health issues. His expertise in the field has positioned him as a valuable asset to the company.
Collaborations
Throughout his career, Adam has collaborated with notable colleagues, including David Andrew Coates and Kwame Frimpong. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Adam Marc Levinson's contributions to pharmaceutical research exemplify the impact of innovation in healthcare. His work on IL-17A inhibitors showcases the potential for new treatments that can improve the quality of life for patients with autoimmune diseases.